Subtherapeutic Doses of Vancomycin Synergize with Bacteriophages for Treatment of Experimental Methicillin-Resistant <i>Staphylococcus aureus</i> Infective Endocarditis

Subtherapeutic Doses of Vancomycin Synergize with Bacteriophages for Treatment of Experimental Methicillin-Resistant <i>Staphylococcus aureus</i> Infective Endocarditis

<b>Background.</b> Recurrent therapeutic failures reported for the treatment of methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) infective endocarditis (IE) with vancomycin may be due to poor bactericidal activity. Alternative antibacterial approaches using bacteriop...

Full description

Bibliographic Details
Main Authors: Jonathan Save, Yok-Ai Que, José Entenza, Grégory Resch
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Viruses
Subjects:
bacteriophage
phage therapy
infective endocarditis
MRSA
vancomycin
Online Access:https://www.mdpi.com/1999-4915/14/8/1792

Internet

https://www.mdpi.com/1999-4915/14/8/1792

Similar Items